Riluzole

Lancet

Volumn 348, Issue 9030, 1996, Pages 795-799

  Wokke, John ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; RILUZOLE;

ASTHENIA; DRUG EFFICACY; DRUG MECHANISM; GRANULOCYTOPENIA; LUNG DISEASE; MOTOR NEURON DISEASE; NAUSEA; PRIORITY JOURNAL; REVIEW; SOMNOLENCE; VERTIGO; VOMITING;

EID: 0030596899     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)03181-9     Document Type: Article

References (38)

1. Tandan R. Clinical features and differential diagnosis of classical motor neuron diseases. In: Williams AC, ed. Motor neuron disease. London: Chapman Hall Medical, 1994: 3-27.
2. Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population: validation of a scoring system and a model for survival prediction. Brain 1995; 118: 707-19.
3. The Scottish Motor Neuron Disease Research group. The Scottish motor neuron disease register: a prospective study of adult onset motor neuron disease in Scotland - methodology, demography and clinical features of incident cases in 1989. J Neurol Neurosurg Psychiatry 1992; 55: 536-41.
4. Drachman DB, Kuncl RW. Amyotrophic lateral sclerosis: an unconventional auto-immune disease? Ann Neurol 1989; 26: 269-74.
5. Fishman PS, Drachman DB. Internalization of IgG in motoneurons of patients with ALS: selective or nonselective? Neurology 1995; 45: 1551-54.
6. Smith RG, Hamilton S, Hofman F, et al. Serum antibodies to L-type calcium channels in patients with amyotrophic lateral sclerosis. N Engl J Med 1992; 327: 1721-28.
7. Drachman DB, Chaudry V, Cornblath D, et al. Trial of immunosuppression in amyotrophic lateral sclerosis using total lymphoid irradiation. Ann Neurol 1994; 35: 142-50.
8. Rosen DR, Siddique T, Patterson Det al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 362:1993;59-62.
9. Deng H-X, Hentati A, Tainer JA, et al. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science 1993; 261: 1047-51.
10. Roos RR, Siddique T, Tainer JA. Summary of 'superoxide dismutase (SOD) and free radicals in amyotrophic lateral sclerosis and degeneration' conference. Neurology 1995; 45: 1779-80.
11. Jones CT, Brook DJH, Chancellor AM, Warlow CP, Swingler RJ. Cu/Zn superoxide dismutase (SOD1) mutations and sporadic amyotrophic lateral sclerosis. Lancet 1993; 342: 1050-51.
12. Gurney ME, Pu H, Chiu AY. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 1994; 264: 1772-75.
13. Shaw PJ, Ince PG, Falkous G, Mantle D. Oxidative damage to protein in sporadic motor neuron disease spinal cord. Ann Neurol 1995; 38: 691-95.
14. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 1994; 330: 613-22.
15. Olney JW. Inciting excitotoxic cytocide among central neurons. Adv Exp Med Biol 1986; 203: 631-45.
16. Coyle JT, Puttfarcken P. Oxidative stress, glutamate and neurodegenerative disorders. Science 1993; 262: 689-95.
17. Rothstein JD, Jin L, Dykes-Hoberg M, Kuncl RW. Chronic inhibition of glutamate uptake produced a model of slow neurotoxicity. Proc Natl Acad Sci USA 1993; 90: 6591-95.
18. Benavides J, Camelin JC, Mitrani N, et al. 2-amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission: II biochemical properties. Neuropharmacology 1985; 24: 1085-92.
19. Mizoule J, Meldrum B, Mazadier M, et al. 2-amino-6-trifluoromethoxy benzothiozole, a possible antagonist of excitatory amino acid neurotransmission: I anticonvulsant properties. Neuropharmacology 1985; 24: 767-73.
20. Malgouris C, Bardot F, Daniel M, et al. Riluzole, a novel antiglutamate, prevents memory loss and hippocampal damage in ischemic gerbils. J Neurosci 1989; 9: 3720-27.
21. Chéramy A, Barbeito L, Godeheu G, Glowinsky J. Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivo. Neurosci Lett 1992; 147: 209-12.
22. 3H]aspartate release from cultured cerebellar granule cells. Neurosci Lett 1992; 140: 251-54.
23. Stutzman JM, Lucas M, Blanchard JC, Laduron PM Riluzole, a glutamate antagonist, enhances slow wave and REM sleep in rats. Neurosci Lett. 88:1988;195-200.
24. Benoit E, Escande D. Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre. Pflügers Arch 1991; 419: 603-09.
25. Couratier Ph, Sindou Ph, Esclaire F, Louvel E, Hugon J. Neuroprotective effects of riluzole in ALS CSF toxicity. NeuroReport 1994; 5: 1012-14.
26. Estevez AG, Stutzmann JM, Barbeito L. Protective effects of riluzole on excitatory amino acid-mediated neurotoxicity in motoneuron-enriched cultures. Eur J Pharmacol. 280:1995;47-53.
27. Rothstein JD, Kuncl RW. Neuroprotective strategies in a model of chronic glutamate-mediated motor neuron toxicity. J Neurochem 1995; 65: 643-51.
28. Gurney ME, Cutting FB, Zhai P, et al. Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann Neurol 1996; 39: 147-57.
29. Bensimon G, Lacomblez L, Meininger V, and the ALS/Riluzole study group. A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med 1994; 330: 585-91.
30. Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V, for the Amyotrophic Lateral Sclerosis Study Group-II. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Lancet 1996; 347: 1425-31.
31. Swash M, Leigh PN Criteria for diagnosis of familial amyotrophic lateral sclerosis: European FALS Collaborative Group. Neuromusc Disord. 2:1992;7-9.
32. Rowland LP. Riluzole for the treatment of amyotrophic lateral sclerosis - too soon to tell? N Engl J Med 1994; 330: 636-37.
33. MacRae K. Riluzole in amyotrophic lateral sclerosis. N Engl J Med 1994; 331: 272-73.
34. Murphy JR Riluzole in amyotrophic lateral sclerosis. N Engl J Med. 331:1994;273.
35. Bensimon G, lacoublez L, Meininger V, for the ALS/Riluzole Study group. Riluzole in amyotrophic lateral sclerosis. N Engl J Med 1994; 331: 273-74.
36. Nightingale SL From the Food and Drug Administration. Riluzole available for ALS under treatment IND. JAMA. 274:1995;292.
37. Barinaga M. Neurotrophic factors enter the clinic. Science 1994; 264: 772-73.
38. Longo FM. Will ciliary neurotrophic factor slow progression of motor neuron disease? Ann Neurol 1994; 36: 125-27.